Masters of Science Degree in Clinical Investigation for Board-Eligible Clinicians
The NYU School of Medicine is proud to offer a Masters of Science degree in Clinical Investigation. Formerly known as the K30 Program, this degree is intended for physicians and other post-doctoral level clinicians interested in gaining the knowledge and research experience necessary to build their careers.
Trainees can pursue a MSCI with a concentration in Translational Medicine, or a concentration in Comparative Effectiveness Research. To learn about the concentration in Translational Medicine, continue reading below. The MSCI with a concentration in Comparative Effectiveness Research is administered by the Department of Population Health: follow this link for more information.
ABOUT THE TRANSLATIONAL MEDICINE PROGRAM
The rapid strides and advancement of biomedical discoveries present an opportunity for clinical care to further improve upon disease prevention, diagnosis, and management. The goal of this training program is to train clinician-scientists in the skills necessary to translate scientific discoveries to clinical settings, to determine the efficacy and outcomes of new and established therapy and identify, using epidemiologic and statistical tools, the health problems of the future. The program is intended for persons who have completed residency training in a clinical department.
To contact us about the Masters of Science in Clinical Investigation program, please email us at email@example.com
Investigators planning to apply for NYU/HHC CTSI support should be aware that it is a requirement that all publications or media resulting from the utilization of its resources credit the CTSI grant by including the NIH Funding acknowledgment and complying with NIH Public Access Policy.